Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Fleur Ferguson

Title(s)Assistant Professor, Chemistry and Biochemistry
SchoolVc-academic Affairs
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Synthesis and Structure-Activity Relationships of CRBN-Recruiting ZBTB11 Molecular Glue Degraders. J Med Chem. 2025 Sep 25; 68(18):19287-19302. Jiang J, Tran NL, Svendsen E, Wang ES, Ferguson FM. PMID: 40911408; PMCID: PMC12481478.
      View in: PubMed   Mentions:    Fields:    
    2. ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC. Nat Chem Biol. 2025 Aug 11. Tran NL, Jiang J, Ma M, Gadbois GE, Gulay KCM, Verano AL, Schiavon CR, Rebollo E, Zhou H, Huang CT, Murad R, Scott DA, Manor U, Bang AG, Tiriac H, Lowy AM, Wang ES, Ferguson FM. PMID: 40789946.
      View in: PubMed   Mentions:    Fields:    
    3. A Lipid Prodrug Strategy Enhances Targeted Protein Degrader CNS Pharmacokinetics. J Med Chem. 2025 Aug 28; 68(16):17339-17349. Leconte GA, Gadbois GE, Sepulveda Y, Schwarz A, Chang E, Suhandynata RT, Momper JD, Ferguson FM. PMID: 40763185.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    4. Development of PROTACs for targeted degradation of oncogenic TRK fusions. bioRxiv. 2025 Jun 24. Kumar S, Jiang J, Donald-Paladino MS, Chen J, Gutierrez A, Federation AJ, Szulzewsky F, Holland EC, Ferguson FM, Nabet B. PMID: 40666929; PMCID: PMC12262543.
      View in: PubMed   Mentions:
    5. FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma. Cancer Cell. 2025 Mar 10; 43(3):428-445.e6. Lubrano S, Cervantes-Villagrana RD, Faraji F, Ramirez S, Sato K, Adame-Garcia SR, Officer A, Arang N, Rigiracciolo DC, Anguiano Quiroz PY, Martini C, Wang Y, Ferguson FM, Bacchiocchi A, Halaban R, Coma S, Holmen SL, Pachter JA, Aplin AE, Gutkind JS. PMID: 40020669; PMCID: PMC11903146.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    6. Thoughts for the future. Nat Chem Biol. 2025 Jan; 21(1):6-15. Alkhalaf LM, Arrowsmith C, Balskus EP, Bergamini G, Bhandari R, Chang CJ, Chen P, Chen X, Ciulli A, Cricco JA, Davis BG, Delbianco M, Dudareva N, Dueber E, Ferguson F, de Giuseppe PO, Hamachi I, Hammond MC, Hatzios SK, Do Heo W, Janet JP, Kamat SS, Knapp S, Krishnan Y, Lang K, Laraia L, Leveson-Gower RB, Li XD, Liu DR, Liu MF, London N, Mahanta N, Mayor-Ruiz C, Muir T, Murakami MT, Rhee HW, Robers M, Satz A, Schulman BA, Shen B, Shoichet B, Strauss E, Suzuki T, Tiwary P, Waldmann H, Ward TR, Weeks A, Weerapana E, Winter G. PMID: 39719500.
      View in: PubMed   Mentions:    Fields:    
    7. A Kinetic Scout Approach Accelerates Targeted Protein Degrader Development. Angew Chem Int Ed Engl. 2025 Jan 27; 64(5):e202417272. Fan AT, Gadbois GE, Huang HT, Chaudhry C, Jiang J, Sigua LH, Smith ER, Wu S, Poirier GJ, Dunne-Dombrink K, Goyal P, Tao AJ, Sellers WR, Fischer ES, Donovan KA, Ferguson FM. PMID: 39602499; PMCID: PMC11890178.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    8. Making transient complexes stick. Nat Chem Biol. 2024 Dec; 20(12):1557-1558. Wang Y, Mouli MSSV, Ma M, Ferguson FM. PMID: 39075251.
      View in: PubMed   Mentions:    Fields:    
    9. A Kinetic Scout Approach Accelerates Targeted Protein Degrader Development. bioRxiv. 2024 Sep 21. Fan AT, Gadbois GE, Huang HT, Jiang J, Sigua LH, Smith ER, Wu S, Dunne-Dombrink K, Goyal P, Tao AJ, Sellers W, Fischer ES, Donovan KA, Ferguson FM. PMID: 39345570; PMCID: PMC11429919.
      View in: PubMed   Mentions:
    10. DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression. Sci Signal. 2024 09 17; 17(854):eabq4888. Afshar-Sterle S, Carli ALE, O'Keefe R, Tse J, Fischer S, Azimpour AI, Baloyan D, Elias L, Thilakasiri P, Patel O, Ferguson FM, Eissmann MF, Chand AL, Gray NS, Busuttil R, Boussioutas A, Lucet IS, Ernst M, Buchert M. PMID: 39288218.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    11. Pan-RAF:MEK Molecular Glues Take Center Stage. Cancer Discov. 2024 Jul 01; 14(7):1143-1144. Hangauer MJ, Gutkind JS, Ferguson FM. PMID: 38946324.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    12. Application of induced proximity for therapeutic discovery. Cell Chem Biol. 2024 Jun 20; 31(6):1036-1038. Cacace A, Daniels D, Ferguson FM, Mayor-Ruiz C, Woo C. PMID: 38906107.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC. bioRxiv. 2024 May 21. Tran NL, Jiang J, Ma M, Gadbois GE, Gulay KCM, Verano A, Zhou H, Huang CT, Scott DA, Bang AG, Tiriac H, Lowy AM, Wang ES, Ferguson FM. PMID: 38826238; PMCID: PMC11142081.
      View in: PubMed   Mentions:
    14. Measuring Ligand-bound Protein Complexes with Proximity Labeling: A Practical Guide. Chembiochem. 2024 May 17; 25(10):e202400073. Goyal P, Tao AJ, Mumby EJ, English JG, Ferguson FM. PMID: 38457625; PMCID: PMC11663430.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. A biotin targeting chimera (BioTAC) system to map small molecule interactomes in situ. Nat Commun. 2023 12 04; 14(1):8016. Tao AJ, Jiang J, Gadbois GE, Goyal P, Boyle BT, Mumby EJ, Myers SA, English JG, Ferguson FM. PMID: 38049406; PMCID: PMC10695998.
      View in: PubMed   Mentions: 8     Fields:    
    16. PROTACs reach clinical development in inflammatory skin disease. Nat Med. 2023 Dec; 29(12):3006-3007. Ferguson FM. PMID: 37957374.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    17. A Biotin Targeting Chimera (BioTAC) System to Map Small Molecule Interactomes in situ. bioRxiv. 2023 Aug 22. Tao AJ, Jiang J, Gadbois GE, Goyal P, Boyle BT, Mumby EJ, Myers SA, English JG, Ferguson FM. PMID: 37662262; PMCID: PMC10473607.
      View in: PubMed   Mentions:
    18. A new avenue for molecular glues: Rapid discovery of a NFKB1 degrader. Cell Chem Biol. 2023 04 20; 30(4):340-342. Fan AT, Boyle BT, Ferguson FM. PMID: 37084716.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    19. Targeted Protein Degradation: Design Considerations for PROTAC Development. Curr Protoc. 2022 Dec; 2(12):e611. Tran NL, Leconte GA, Ferguson FM. PMID: 36469581; PMCID: PMC9729011.
      View in: PubMed   Mentions: 7     Fields:    Translation:Cells
    20. Editorial: E3 ubiquitin ligases: From structure to physiology to therapeutics, Volume II. Front Physiol. 2022; 13:1038793. Licchesi JDF, Laman H, Ikeda F, Ferguson FM, Bolanos-Garcia VM. PMID: 36237534; PMCID: PMC9553087.
      View in: PubMed   Mentions:
    21. Tuned out. Nat Chem Biol. 2022 Sep; 18(9):917-918. Ferguson FM. PMID: 35590002.
      View in: PubMed   Mentions: 1     Fields:    
    22. Discovery and Optimization of Tau Targeted Protein Degraders Enabled by Patient Induced Pluripotent Stem Cells-Derived Neuronal Models of Tauopathy. Front Cell Neurosci. 2022; 16:801179. Silva MC, Nandi G, Donovan KA, Cai Q, Berry BC, Nowak RP, Fischer ES, Gray NS, Ferguson FM, Haggarty SJ. PMID: 35317195; PMCID: PMC8934437.
      View in: PubMed   Mentions: 18  
    23. Targeted protein degradation: Emerging concepts and protein state-specific targeting principles. Curr Opin Chem Biol. 2022 04; 67:102114. Tao AJ, Gadbois GE, Buczynski SA, Ferguson FM. PMID: 35042023; PMCID: PMC9701552.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    24. Synthesis and structure-activity relationships of targeted protein degraders for the understudied kinase NEK9. Curr Res Chem Biol. 2021; 1. Ryu S, Gadbois GE, Tao AJ, Fram BJ, Jiang J, Boyle B, Donovan KA, Krupnick NM, Berry BC, Bhunia D, Shin I, Fischer ES, Gray NS, Sim T, Ferguson FM. PMID: 40837099; PMCID: PMC12364016.
      View in: PubMed   Mentions:
    25. TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma. Cancer Cell. 2021 09 13; 39(9):1262-1278.e7. Seong BKA, Dharia NV, Lin S, Donovan KA, Chong S, Robichaud A, Conway A, Hamze A, Ross L, Alexe G, Adane B, Nabet B, Ferguson FM, Stolte B, Wang EJ, Sun J, Darzacq X, Piccioni F, Gray NS, Fischer ES, Stegmaier K. PMID: 34329586; PMCID: PMC8443273.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    26. Assembling a Robust Workflow for Characterizing Endogenous E3 Ligase Substrates. Biochemistry. 2021 08 10; 60(31):2365-2366. Tao AJ, Ferguson FM. PMID: 34077180.
      View in: PubMed   Mentions:    Fields:    
    27. Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells. Proteomics. 2021 07; 21(13-14):e2000098. Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M. PMID: 33991177.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    28. Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma. Eur J Med Chem. 2021 Oct 05; 221:113481. Jiang B, Jiang J, Kaltheuner IH, Iniguez AB, Anand K, Ferguson FM, Ficarro SB, Seong BKA, Greifenberg AK, Dust S, Kwiatkowski NP, Marto JA, Stegmaier K, Zhang T, Geyer M, Gray NS. PMID: 33945934; PMCID: PMC12442338.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    29. Harnessing Antibody-Mimetic Selectivity for Activation-State-Specific Targeted Degradation of Endogenous K-Ras. ACS Cent Sci. 2021 Feb 24; 7(2):222-224. Ferguson FM. PMID: 33655060; PMCID: PMC7908021.
      View in: PubMed   Mentions: 2  
    30. Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development. Cell. 2020 12 10; 183(6):1714-1731.e10. Donovan KA, Ferguson FM, Bushman JW, Eleuteri NA, Bhunia D, Ryu S, Tan L, Shi K, Yue H, Liu X, Dobrovolsky D, Jiang B, Wang J, Hao M, You I, Teng M, Liang Y, Hatcher J, Li Z, Manz TD, Groendyke B, Hu W, Nam Y, Sengupta S, Cho H, Shin I, Agius MP, Ghobrial IM, Ma MW, Che J, Buhrlage SJ, Sim T, Gray NS, Fischer ES. PMID: 33275901; PMCID: PMC10294644.
      View in: PubMed   Mentions: 127     Fields:    Translation:HumansCells
    31. Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules. Nat Commun. 2020 09 18; 11(1):4687. Nabet B, Ferguson FM, Seong BKA, Kuljanin M, Leggett AL, Mohardt ML, Robichaud A, Conway AS, Buckley DL, Mancias JD, Bradner JE, Stegmaier K, Gray NS. PMID: 32948771; PMCID: PMC7501296.
      View in: PubMed   Mentions: 145     Fields:    Translation:HumansAnimalsCells
    32. Correction to "Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one Scaffold". J Med Chem. 2020 Sep 10; 63(17):10088. Ferguson FM, Liu Y, Harshbarger W, Huang L, Wang J, Deng X, Capuzzi SJ, Muratov EN, Tropsha A, Muthuswamy S, Westover KD, Gray NS. PMID: 32790356; PMCID: PMC9205600.
      View in: PubMed   Mentions:    Fields:    
    33. Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing. Cell Chem Biol. 2020 10 15; 27(10):1229-1240.e4. Liu Y, Ferguson FM, Li L, Kuljanin M, Mills CE, Subramanian K, Harshbarger W, Gondi S, Wang J, Sorger PK, Mancias JD, Gray NS, Westover KD. PMID: 32755567; PMCID: PMC8053042.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    34. Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one Scaffold. J Med Chem. 2020 07 23; 63(14):7817-7826. Ferguson FM, Liu Y, Harshbarger W, Huang L, Wang J, Deng X, Capuzzi SJ, Muratov EN, Tropsha A, Muthuswamy S, Westover KD, Gray NS. PMID: 32530623; PMCID: PMC8270059.
      View in: PubMed   Mentions: 11     Fields:    Translation:Cells
    35. Selective Mediator dependence of cell-type-specifying transcription. Nat Genet. 2020 07; 52(7):719-727. Jaeger MG, Schwalb B, Mackowiak SD, Velychko T, Hanzl A, Imrichova H, Brand M, Agerer B, Chorn S, Nabet B, Ferguson FM, Müller AC, Bergthaler A, Gray NS, Bradner JE, Bock C, Hnisz D, Cramer P, Winter GE. PMID: 32483291; PMCID: PMC7610447.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    36. Discovery and Structure-Activity Relationship Study of (Z)-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors. J Med Chem. 2020 05 14; 63(9):4880-4895. Manz TD, Sivakumaren SC, Ferguson FM, Zhang T, Yasgar A, Seo HS, Ficarro SB, Card JD, Shim H, Miduturu CV, Simeonov A, Shen M, Marto JA, Dhe-Paganon S, Hall MD, Cantley LC, Gray NS. PMID: 32298120; PMCID: PMC7292230.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    37. Discovery of a selective inhibitor of doublecortin like kinase 1. Nat Chem Biol. 2020 06; 16(6):635-643. Ferguson FM, Nabet B, Raghavan S, Liu Y, Leggett AL, Kuljanin M, Kalekar RL, Yang A, He S, Wang J, Ng RWS, Sulahian R, Li L, Poulin EJ, Huang L, Koren J, Dieguez-Martinez N, Espinosa S, Zeng Z, Corona CR, Vasta JD, Ohi R, Sim T, Kim ND, Harshbarger W, Lizcano JM, Robers MB, Muthaswamy S, Lin CY, Look AT, Haigis KM, Mancias JD, Wolpin BM, Aguirre AJ, Hahn WC, Westover KD, Gray NS. PMID: 32251410; PMCID: PMC7246176.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    38. Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors. Cell Chem Biol. 2020 05 21; 27(5):525-537.e6. Sivakumaren SC, Shim H, Zhang T, Ferguson FM, Lundquist MR, Browne CM, Seo HS, Paddock MN, Manz TD, Jiang B, Hao MF, Krishnan P, Wang DG, Yang TJ, Kwiatkowski NP, Ficarro SB, Cunningham JM, Marto JA, Dhe-Paganon S, Cantley LC, Gray NS. PMID: 32130941; PMCID: PMC7286548.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    39. Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors. ACS Med Chem Lett. 2020 Mar 12; 11(3):346-352. Manz TD, Sivakumaren SC, Yasgar A, Hall MD, Davis MI, Seo HS, Card JD, Ficarro SB, Shim H, Marto JA, Dhe-Paganon S, Sasaki AT, Boxer MB, Simeonov A, Cantley LC, Shen M, Zhang T, Ferguson FM, Gray NS. PMID: 32184968; PMCID: PMC7074221.
      View in: PubMed   Mentions: 14  
    40. Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold. ACS Med Chem Lett. 2019 Oct 10; 10(10):1443-1449. Remillard D, Buckley DL, Seo HS, Ferguson FM, Dhe-Paganon S, Bradner JE, Gray NS. PMID: 31620231; PMCID: PMC6792166.
      View in: PubMed   Mentions: 7  
    41. Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14. Bioorg Med Chem Lett. 2019 08 01; 29(15):1985-1993. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS. PMID: 31175010; PMCID: PMC6886737.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity. Cell Chem Biol. 2019 06 20; 26(6):804-817.e12. Ferguson FM, Doctor ZM, Ficarro SB, Browne CM, Marto JA, Johnson JL, Yaron TM, Cantley LC, Kim ND, Sim T, Berberich MJ, Kalocsay M, Sorger PK, Gray NS. PMID: 30930164; PMCID: PMC6588450.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    43. Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models. Elife. 2019 03 25; 8. Silva MC, Ferguson FM, Cai Q, Donovan KA, Nandi G, Patnaik D, Zhang T, Huang HT, Lucente DE, Dickerson BC, Mitchison TJ, Fischer ES, Gray NS, Haggarty SJ. PMID: 30907729; PMCID: PMC6450673.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    44. Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains. ACS Chem Biol. 2018 09 21; 13(9):2438-2448. Wang J, Erazo T, Ferguson FM, Buckley DL, Gomez N, Muñoz-Guardiola P, Diéguez-Martínez N, Deng X, Hao M, Massefski W, Fedorov O, Offei-Addo NK, Park PM, Dai L, DiBona A, Becht K, Kim ND, McKeown MR, Roberts JM, Zhang J, Sim T, Alessi DR, Bradner JE, Lizcano JM, Blacklow SC, Qi J, Xu X, Gray NS. PMID: 30102854; PMCID: PMC6333101.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    45. Kinase inhibitors: the road ahead. Nat Rev Drug Discov. 2018 05; 17(5):353-377. Ferguson FM, Gray NS. PMID: 29545548.
      View in: PubMed   Mentions: 393     Fields:    Translation:HumansAnimalsCells
    46. Characterization of a highly selective inhibitor of the Aurora kinases. Bioorg Med Chem Lett. 2017 09 15; 27(18):4405-4408. Ferguson FM, Doctor ZM, Chaikuad A, Sim T, Kim ND, Knapp S, Gray NS. PMID: 28818446; PMCID: PMC11892687.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    47. Discovery of a Series of 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-ones as Selective PI3K-δ/γ Inhibitors. ACS Med Chem Lett. 2016 Oct 13; 7(10):908-912. Ferguson FM, Ni J, Zhang T, Tesar B, Sim T, Kim ND, Deng X, Brown JR, Zhao JJ, Gray NS. PMID: 27774127; PMCID: PMC5066161.
      View in: PubMed   Mentions: 6  
    48. Molecular basis of histone tail recognition by human TIP5 PHD finger and bromodomain of the chromatin remodeling complex NoRC. Structure. 2015 Jan 06; 23(1):80-92. Tallant C, Valentini E, Fedorov O, Overvoorde L, Ferguson FM, Filippakopoulos P, Svergun DI, Knapp S, Ciulli A. PMID: 25533489; PMCID: PMC4291147.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    49. Binding hotspots of BAZ2B bromodomain: Histone interaction revealed by solution NMR driven docking. Biochemistry. 2014 Oct 28; 53(42):6706-16. Ferguson FM, Dias DM, Rodrigues JP, Wienk H, Boelens R, Bonvin AM, Abell C, Ciulli A. PMID: 25266743; PMCID: PMC4458377.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    50. Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain. J Med Chem. 2013 Dec 27; 56(24):10183-7. Ferguson FM, Fedorov O, Chaikuad A, Philpott M, Muniz JR, Felletar I, von Delft F, Heightman T, Knapp S, Abell C, Ciulli A. PMID: 24304323; PMCID: PMC3905694.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    Fleur's Networks
    Concepts (162)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (16)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California